Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

NCT: NCT04197921 · RECRUITING

NCT IDNCT04197921
StatusRECRUITING
Start Date2019-11-27
Completion2027-12-31
SponsorInSightec (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this clinical trial is to investigate Low Intensity Focused Ultrasound (LIFU) using the Exablate® Model 4000 Type 2.0/2.1 as an adjunctive neuromodulatory treatment for OUD (Opioid Use Disorder) and/or other Substance Use Disorders (SUDs) by assessing its safety and tolerability in subjects with OUD.

Frequently Asked Questions

What is Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)?

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) is a clinical trial registered under NCT04197921. Current status: RECRUITING.

What is the status of NCT04197921?

The current status of NCT04197921 (Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)) is: RECRUITING.

When did Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) start?

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs) started on 2019-11-27.

Related Devices

PMA P040003Ablation system, high intensity focused ultrasound (HIFU), MR-guidedInsightec, Ltd. PMA P110039Ablation system, high intensity focused ultrasound (HIFU), MR-guidedInsightec K231378Exablate Model 2100V1, Exablate Prostate System, Exablate MRgFUS, Exablate 2100V1 Type 3.0Insightec, Ltd. PMA P150038MR-guided focused ultrasound systemInsightec K212150Exablate Prostate SystemInsightec, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑